GOLD COPD 2025: The Global Forum for COPD Innovation in Philadelphia
The 2025 GOLD International COPD Conference will take place from November 12–13, 2025, in Philadelphia, Pennsylvania (USA), hosted by the Temple Lung Center in collaboration with the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
This two-day hybrid conference brings together pulmonologists, radiologists, researchers, and healthcare innovators from around the world to discuss the latest clinical updates, AI-driven diagnostics, and integrated care strategies for COPD.
Event Overview
• Event: 2025 GOLD International COPD Conference
• Dates: November 12–13, 2025
• Location: Philadelphia, Pennsylvania, USA
• Format: Hybrid (On-site + Virtual)
• Organizers: Temple Lung Center & GOLD Initiative
Key Highlights
• GOLD 2025 Report Launch
The conference will unveil the updated GOLD 2025 guidelines, highlighting new diagnostic criteria, management strategies, and treatment pathways for COPD.
• Clinical and Practical Sessions
Topics include AI in COPD assessment, comorbidity management, radiologic evaluation, and multidisciplinary collaboration in real-world practice.
• Focus on Cardiovascular Comorbidities
The updated GOLD 2025 report emphasizes cardiovascular risks and pulmonary hypertension (PH) among COPD patients — a key area of focus for this year’s discussions.
• Environment and COPD
Sessions will address how climate change, pollution, and occupational exposure contribute to COPD incidence and progression.
• Global Access Through Hybrid Format
Participants can attend in person or join virtually from anywhere, expanding access for international clinicians and researchers.
Coreline Soft’s Perspective
At GOLD COPD 2025, Coreline Soft continues its mission to redefine thoracic imaging through AI.
With a strong presence in Korea, Europe, and Australia, Coreline’s AVIEW platform supports early detection and longitudinal management of COPD and its comorbidities.
• Our AI solutions include:
AVIEW COPD: Quantitative CT analysis for early diagnosis and follow-up of COPD.
AVIEW LCS Plus: Integrated lung cancer screening and emphysema quantification from a single LDCT scan.
AVIEW CAC: Automated coronary calcium scoring to assess cardiovascular risk in COPD patients.
These solutions align with the GOLD initiative’s goal of personalized and data-driven respiratory care.
Why GOLD COPD 2025 Matters
As global COPD prevalence continues to rise, this conference serves as the epicenter for evidence-based medicine and technological innovation in respiratory care.
From predictive modeling to AI-enhanced imaging, GOLD COPD 2025 will showcase how data and digital health are shaping a new era of precision pulmonology.
The GOLD COPD 2025 conference in Philadelphia represents a pivotal moment for clinicians, scientists, and innovators working to improve COPD outcomes worldwide.
Join Coreline Soft as we engage with global experts to explore how AI, imaging analytics, and clinical integration can transform the future of chronic respiratory care.
Add the event to your Google Calendar and stay tuned for more updates from Coreline Soft on the future of AI-powered lung health.
